Risk of hepatocellular carcinoma and cancers at other sites among patients diagnosed with chronic hepatitis B virus infection in Sweden

Journal of Medical Virology

Volumn 86, Issue 1, 2014, Pages 18-22

  Sundquist, Kristina ^a,b   Sundquist, Jan ^a,b   Ji, Jianguang ^a  

^a LUND UNIVERSITY   (Sweden)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Hepatitis B virus; Leukemia; Liver cancer; Lymphoma

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; CANCER LOCALIZATION; CANCER REGISTRY; CANCER RISK; COHORT ANALYSIS; FEMALE; HEPATITIS B; HODGKIN DISEASE; HUMAN; KIDNEY CANCER; LARYNX CANCER; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MYELOMA; NONHODGKIN LYMPHOMA; SKIN CARCINOMA; SWEDEN; THYROID CANCER;

HEPATITIS B VIRUS;

HEPATITIS B VIRUS; LEUKEMIA; LIVER CANCER; LYMPHOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATITIS B, CHRONIC; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS; RISK ASSESSMENT; RISK FACTORS; SWEDEN; YOUNG ADULT;

EID: 84887820094     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23754     Document Type: Article

References (32)

1. Amin J, Dore GJ, O'Connell DL, Bartlett M, Tracey E, Kaldor JM, Law MG. 2006. Cancer incidence in people with hepatitis B or C infection: A large community-based linkage study. J Hepatol 45:197-203.
2. Becker N, Schnitzler P, Boffetta P, Brennan P, Foretova L, Maynadie M, Nieters A, Staines A, Benavente Y, Cocco P, de Sanjose S. 2012. Hepatitis B virus infection and risk of lymphoma: Results of a serological analysis within the European case-control study Epilymph. J Cancer Res Clin Oncol 138:1993-2001.
3. Breslow NE, Day NE. 1987. Statistical methods in cancer research. Volume 2-The design and analysis of cohort studies. Lyon, France: International Agency for Research on Cancer, Inc. 406 p.
4. Centre for Epidemiology. 2008. Cancer incidence in Sweden 2007. Stockholm, Sweden: The National Board of Health and Welfare, Inc. 117 p.
5. Chen CJ, Wang LY, Yu MW. 2000. Epidemiology of hepatitis B virus infection in the Asia-Pacific region. J Gastroenterol Hepatol 15:E3-E6.
6. Chien RN, Yeh CT, Wang PN, Kuo MC, Hsieh SY, Shih LY, Liaw YF. 2004. Acute leukaemia in chronic hepatitis B patients with lamivudine therapy. Int J Clin Pract 58:1088-1091.
7. Cogliano VJ, Baan R, Straif K, Grosse Y, Lauby-Secretan B, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Wild CP. 2011. Preventable exposures associated with human cancers. J Natl Cancer Inst 103:1827-1839.
8. Crook PD, Jones ME, Hall AJ. 2003. Mortality of hepatitis B surface antigen-positive blood donors in England and Wales. Int J Epidemiol 32:118-124.
9. Custer B, Sullivan SD, Hazlet TK, Iloeje U, Veenstra DL, Kowdley KV. 2004. Global epidemiology of hepatitis B virus. J Clin Gastroenterol 38:S158-S168.
10. Davidsdottir L, Duberg AS, Torner A, Aleman S, Back E, Ekdahl K, Blaxhult A, Ekbom A, Hultcrantz R. 2010. Hepatocellular carcinoma in individuals with HBV infection or HBV-HCV co-infection in a low endemic country. Scand J Gastroenterol 45:944-952.
11. Deutsch M, Dourakis S, Manesis EK, Gioustozi A, Hess G, Horsch A, Hadziyannis S. 1997. Thyroid abnormalities in chronic viral hepatitis and their relationship to interferon alfa therapy. Hepatology 26:206-210.
12. Dienstag JL. 2008. Hepatitis B virus infection. N Engl J Med 359:1486-1500.
13. Esteve J, Benhamou E, Raymond L. 1994. Statistical methods in cancer research. Lyon, France: IARC, Inc. 302 p.
14. Fiorino S, Chili E, Bacchi-Reggiani L, Masetti M, Deleonardi G, Grondona AG, Silvestri T, Magrini E, Zanini N, Cuppini A, Nardi R, Jovine E. 2013. Association between hepatitis B or hepatitis C virus infection and risk of pancreatic adenocarcinoma development: A systematic review and meta-analysis. Pancreatology 13:147-160.
15. Fouillard L, Serfaty L, Gozlan J. 2006. Adefovir therapy for lamivudine escape and hepatitis B virus reactivation after reduced intensity conditioning allogeneic stem cell transplantation. Bone Marrow Transplant 37:625-626.
16. International Agency for Research on Cancer. 1994. IARC monograph on the evaluation of carcinogenic risks to humans. Hepatitis viruses. Vol. 59. Lyon, France: International Agency for Research on Cancer, Inc. 286 p.
17. International Agency for Research on Cancer. 2011. IARC Monograph on the evaluation of carcinogenic risks to humans. Biological agents. Vol. 100B. Lyon: International Agency for Research on Cancer, Inc. 485 p.
18. Kim JH, Bang YJ, Park BJ, Yoo T, Kim CW, Kim TY, Heo DS, Lee HS, Kim NK. 2002. Hepatitis B virus infection and B-cell non-Hodgkin's lymphoma in a hepatitis B endemic area: A case-control study. Jpn J Cancer Res 93:471-477.
19. Lee WM. 1997. Hepatitis B virus infection. N Engl J Med 337:1733-1745.
20. Lindh M, Horal P, Norkrans G. 2000. Acute hepatitis B in Western Sweden-genotypes and transmission routes. Infection 28:161-163.
21. Loomba R, Liu J, Yang HI, Lee MH, Lu SN, Wang LY, Iloeje UH, You SL, Brenner D, Chen CJ. 2013. Synergistic effects of family history of hepatocellular carcinoma and hepatitis B virus infection on risk for incident hepatocellular carcinoma. Clin Gastroenterol Hepatol pii: S1542-3565(13)00618-6
22. Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim JL, Reuterwall C, Heurgren M, Olausson PO. 2011. External review and validation of the Swedish national inpatient register. BMC Public Health 11:450-466.
23. Luo G, Hao NB, Hu CJ, Yong X, Lu MH, Cheng BJ, Zhang Y, Yang SM. 2013. HBV infection increases the risk of pancreatic cancer: A meta-analysis. Cancer Causes Control 24:529-537.
24. Marshall MM, Kirk GD, Caporaso NE, McCormack MC, Merlo CA, Hague JC, Mehta SH, Engels EA. 2011. Tobacco use and nicotine dependence among HIV-infected and uninfected injection drug users. Addict Behav 36:61-67.
25. Rantala M, van de Laar MJ. 2008. Surveillance and epidemiology of hepatitis B and C in Europe-A review. Euro Surveill 13:8 p.
26. Ribes J, Cleries R, Rubio A, Hernandez JM, Mazzara R, Madoz P, Casanovas T, Casanova A, Gallen M, Rodriguez C, Moreno V, Bosch FX. 2006. Cofactors associated with liver disease mortality in an HBsAg-positive Mediterranean cohort: 20 years of follow-up. Int J Cancer 119:687-694.
27. Rothman KJ, Greenland S. 1998. Modern epidemiology. 2nd edition. Philadelphia, PA: Lippincott-Raven Publishers, Inc. 737 p.
28. Shu X, Ji J, Li X, Sundquist J, Sundquist K, Hemminki K. 2010. Cancer risk in patients hospitalised for Graves' disease: A population-based cohort study in Sweden. Br J Cancer 102:1397-1399.
29. Soderstrom A, Lindh M, Eriksson K, Horal P, Krantz M, Kristiansson B, Lindberg J, Norkrans G. 1999. Chronic hepatitis B in children in Gothenburg, Sweden. Scand J Infect Dis 31:109-114.
30. Struve J, Giesecke J, Lindh G, Weiland O. 1990. Heterosexual contact as a major route for transmission of acute hepatitis B among adults. J Infect 20:111-121.
31. Su FH, Chang SN, Chen PC, Sung FC, Huang SF, Chiou HY, Su CT, Lin CC, Yeh CC. 2012. Positive association between hepatitis C infection and oral cavity cancer: A nationwide population-based cohort study in Taiwan. PLoS One 7:e48109.
32. Ulcickas Yood M, Quesenberry CP, Jr., Guo D, Caldwell C, Wells K, Shan J, Sanders L, Skovron ML, Iloeje U, Manos MM. 2007. Incidence of non-Hodgkin's lymphoma among individuals with chronic hepatitis B virus infection. Hepatology 46:107-11112.